Frontotemporal disorder, also known as Pick disease, is a neurology disorder resulting in the damage of nerve cells in a specific area in the brain, that is, frontal and temporal lobes. Frontotemporal disorders are the leading cause of dementia, affecting behavior, language, personality, and movement. Symptoms of frontotemporal disorders make it difficult for people to perform everyday activities, such as, thinking, walking, socializing, or talking. Mutation of different genes, such as, Tau gene, PGRN gene, VCP, CHMP2B, TARDBP, FUS genes, and C9ORF72 gene are likely to cause frontotemporal disorders, although the exact cause of the disorders is not known. Till date, there has been no curable treatment for frontotemporal disorders, but a few medications are able to help in reducing the disturbance and despondency. Common symptoms of frontotemporal disorders include perseveration, utilization behavior, social disinhibition, dysarthria, aphasia, social-interpersonal changes, emotional changes, gait disorder, dystonia, apraxia, etc. 

Diagnosis of frontotemporal disorders can be confirmed through genetic tests, physical examinations, and blood tests. These tests helps to understand similar conditions, genetic mutation tests, and brain imaging changes in temporal and frontal lobes. Generally, onset of this disorder occurs in the age range of 50 to 60 years, and affected 50,000 to 60,000 Americans in 2011. Antidepressants and antipsychotics medications can help in curing the symptoms of frontotemporal disorders. Ongoing clinical trials are expected to find a treatment for these disorder in the near future, with investment support from giant pharmaceutical companies. 

Factors driving the global frontotemporal disorders treatment market are increase in aging population, growing incidences of frontotemporal disorders, and advanced care of treatment. Frontotemporal disorders not only affect the patients but also the people related to the patients, mentally as well as emotionally. Advanced care of treatment, such as, home care administrations, mental treatment centers, and restorative devices are the major drivers of growth of the global frontotemporal disorders treatment market. However, certain factors, such as, poor treatment process, stringent government regulations, unapproved drugs, and lack of awareness are restraining the growth of the global frontotemporal disorder treatment market. 

The global frontotemporal disorders treatment market is segmented on the basis of drugs, disease type, end-user, and region. Based on drugs, the global frontotemporal disorders treatment can be bifurcated into antidepressants and antipsychotics. Antidepressants, such as, sertraline, fluoxetine, fluvoxamine, bupropion, mitrazepine, etc. are used for managing frontotemporal disorders, while antipsychotics, such as, risperidone, ziprasidone, aripiprazole, quetiapine, etc. are used for managing frontotemporal indications. Based on disease type, the global frontotemporal disorders treatment market can be classified into behavioral variant frontotemporal dementia and primary progressive aphasia (PPA), which is further categorized into In semantic PPA, In agrammatic PPA, and In logopenic PPA, and movement disorders. Movement disorders include corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). Based on end-user, the global frontotemporal disorders treatment market can be divided into hospitals, clinics, and others. 

In terms of region, the global frontotemporal disorders treatment market can be segmented into North America, Europe, Asia Pacific, the Middle East, and Latin America. North America is the leading frontotemporal disorders treatment market, followed by Europe and Asia Pacific. North America leads the frontotemporal disorders treatment market owing to increasing awareness about frontotemporal disorders, changing lifestyle of people, advanced health care facilities, and rise in income in the region. In Asia Pacific, rising prevalence of frontotemporal disorders and growing geriatric population are expected to positively contribute to the growth of the frontotemporal disorders treatment market in the region during the forecast period. 

Players leading the global frontotemporal disorders treatment market include Pfizer Inc., Novartis AG, F. Hoffmann-La Roche Ltd., AstraZeneca plc, Sanofi S.A, and Merck & Co., Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Frontotemporal Disorders Treatment Market

Pre Book